Color-stable whitening compositions and skin-whitening products
By combining arbutin, tranexamic acid, ascorbate glucoside, and ergothioneine, the problem of color change during the compounding process of skin care products is solved, achieving stable color and effective skin whitening effect.
Patent Information
- Application Number
- CN202411041463.2
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2024-07-31
- Publication Date
- 2026-11-17
- Estimated Expiration
- 2044-07-31
AI Technical Summary
Existing skincare products are prone to color changes during the compounding process, affecting the user experience and whitening effect.
The combination of arbutin, tranexamic acid, and color stabilizers (ascorbate glucoside and ergothioneine) maintains the color stability and whitening effect of the composition by inhibiting melanin production and oxidation.
The color stability of the whitening composition is achieved, preventing discoloration, while also providing excellent skin whitening and antioxidant effects.
Smart Images

Figure CN119157764B_ABST
Abstract
Description
Technical Field
[0001] Embodiments of this disclosure relate to the field of biotechnology, specifically to color-stable whitening compositions and skin whitening products. Background Technology
[0002] Excessive pigment production due to external environmental factors, genetics, endocrine disorders, and unhealthy lifestyle habits leads to dull skin and age spots, becoming a major skin concern. Melanin, as a primary determinant of skin color, has a close influence on the degree of skin darkening due to its content and distribution. Specifically, the human body mainly produces eumelanin and pheomelanin. The quantity and ratio of eumelanin and pheomelanin deposited in the epidermis determine a person's skin color; in practice, the lower the ratio, the lighter the skin tone. Currently, common skincare products often aim to achieve skin whitening by focusing on UV protection, melanin inhibition, and melanin transport.
[0003] However, common skin care products often consist of at least one component, and different components may cause color changes when combined.
[0004] The information disclosed in this background section is only intended to enhance the understanding of the background of the inventive concept, and therefore may contain information that does not form prior art known to those skilled in the art. Summary of the Invention
[0005] The summary portion of this disclosure is intended to provide a brief overview of the concepts, which will be described in detail in the detailed description portion. This summary portion is not intended to identify key or essential features of the claimed technical solutions, nor is it intended to limit the scope of the claimed technical solutions.
[0006] Some embodiments of this disclosure provide color-stable whitening compositions and skin-whitening products to address one or more of the technical problems mentioned in the background section above.
[0007] In a first aspect, some embodiments of this disclosure provide a color-stabilized whitening composition comprising: arbutin; tranexamic acid; and a color stabilizer, wherein the color stabilizer comprises: ascorbate glucoside and ergothioneine.
[0008] Optionally, the mass ratio of the above-mentioned arbutin to the above-mentioned tranexamic acid is 1:0.5 to 5.
[0009] Optionally, the mass ratio of the above-mentioned arbutin to the above-mentioned color stabilizer is 1:0.05 to 1.
[0010] Optionally, the mass ratio of the above-mentioned ascorbate glucoside and ergothioneine is 10 to 100:1.
[0011] Optionally, the whitening composition may further include one or more of the following: whitening agent, pH adjuster, and skin feel adjuster.
[0012] Optionally, the aforementioned skin feel modifiers include one or more of the following: humectants, emulsifiers, thickeners, and surfactants.
[0013] Optionally, the whitening composition may also include other whitening ingredients besides whitening agents, wherein the whitening ingredients may include: phenylethyl resorcinol, niacinamide, acetylglucosamine, tetrahydrocurcumin, glycyrrhizin, licorice root extract, ellagic acid, punicein, phloretin, methyl chalcone hesperidin, glucosyl hesperidin, hesperidin, naringin, resveratrol, ascorbate tetraisostearate, kojic acid, glutathione, raspberry glucoside, 4-butylresorcinol, succinic acid, salicylic acid, acetyltyrosine, disaccharosyl gallic acid, and acetylglucosamine. One or more of the following: sodium heparin, AHAs, BHAs, azelaic acid MEA, azelaic acid, potassium 4-methoxysalicylate, polygalactoside, sulforaphane, ferulic acid, adenosine, algae extract, hydrolyzed conchiolin, EGCG, lactobionic acid, lactic acid, tartaric acid, gluconolactone, nonapeptide-1, daisy extract, aloe-emodin, dihydromyricetin, undecenoyl phenylalanine, sea fennel callus culture medium, papain, bromelain, sutyllanase, octadecenoic acid, hexyldecyl alcohol, idebenone, and astaxanthin.
[0014] Optionally, the pH adjuster may include one or more of the following: hydroxyethylpiperazine ethanesulfonic acid, citric acid, sodium citrate, disodium hydrogen phosphate, and sodium dihydrogen phosphate.
[0015] Optionally, the thickener includes: natural thickeners, semi-synthetic thickeners, and synthetic thickeners.
[0016] Optionally, the aforementioned natural thickeners include one or more of the following: prickly pear gum, xanthan gum, agarose, cellulose gum, carrageenan, pullulan, sphingosine gum, sodium alginate, carob gum, and guar gum.
[0017] Optionally, semi-synthetic thickeners include one or more of hydroxyethyl cellulose, hydroxypropyl cellulose, and hydroxypropyl methyl cellulose.
[0018] Optionally, synthetic thickeners may include one or more of the following: carbomer, sodium polyacrylate, acrylate / C10-C30 alkanol acrylate copolymer, acrylate / C10-C30 alkanol acrylate crosslinking copolymer, acrylate copolymer, polyacrylate-1 crosslinking polymer, acrylic acid / acryloyl nitrogen copolymer, acrylate / stearyl ether (20) methacrylate copolymer, acrylate / behenol ether (25) methacrylate copolymer, acrylate / stearyl ether-20 itaconic acid copolymer, acrylate / amino acrylate copolymer, acrylate / vinyl isodecanoate crosslinking polymer, ammonium acryloyl dimethyl taurate / behenol ether-25 methacrylate crosslinking polymer, sodium acryloyl dimethyl taurate / VP crosslinking polymer, and ammonium acryloyl dimethyl taurate / VP copolymer.
[0019] Secondly, some embodiments of this disclosure provide a skin whitening product comprising a color-stabilized whitening composition as described in the first aspect.
[0020] Optionally, the aforementioned skin whitening products include one or more of the following: aqueous solutions, emulsions, creams, ointments, gels, and masks.
[0021] Thirdly, some embodiments of this disclosure provide the application of ascorbate glucoside and ergothioneine as color stabilizers in a whitening composition, wherein the whitening composition includes arbutin and tranexamic acid.
[0022] The above-described embodiments of this disclosure have the following beneficial effects: the color-stable whitening compositions of some embodiments of this disclosure solve the problem of possible color change when different components are compounded. In practice, arbutin, as a whitening ingredient, is mainly classified into three types: α-arbutin, β-arbutin, and D-arbutin. As a naturally occurring glucosinolate hydroquinone derivative, it can achieve whitening by inhibiting the activity of tyrosinase in the melanin synthesis process. Tranexamic acid, as a synthetic lysine derivative, can inhibit plasminogen activation by blocking the lysine binding site on the plasminogen molecule, inhibit ultraviolet-induced plasmin activity, and indirectly affect melanin production by reducing the production of prostaglandins (PGE2). Although tranexamic acid has good stability due to its single water solubility, it can cause color change or browning when compounded with common cosmetic ingredients. Studies have found that tranexamic acid reacts with sugars, including polyhydroxy sugar derivatives, to produce browning. Practice has shown that when arbutin and tranexamic acid are used alone, the actual active ingredient content does not change significantly, but discoloration occurs, affecting the user experience. Therefore, this disclosure attempts to add antioxidants, such as a high content of sodium metabisulfite, to arbutin and tranexamic acid. However, further research revealed that sodium metabisulfite produces sulfur dioxide, resulting in a strong, irritating odor. Furthermore, sodium metabisulfite has high conductivity and is highly ionic, requiring the formulation of a thickener with strong anti-ionic properties. However, this type of thickener has a poor skin feel and imposes significant limitations on the formulation. Based on this, this disclosure attempts to add ascorbate glucoside and ergothioneine as color stabilizers to arbutin and tranexamic acid. Experiments have shown that the color-stabilized whitening composition of this disclosure, including tranexamic acid and arbutin, can complement each other in the melanin formation metabolic pathway, achieving a whitening effect by inhibiting melanin production. Simultaneously, the use of ascorbate glucoside and ergothioneine as color stabilizers ensures the color stability of the whitening composition. Furthermore, ascorbate glucoside releases vitamin C through hydrolysis by glycosidases within skin cells, directly reducing dark oxidized melanin to lighter reduced pigments, thus achieving a whitening effect. Simultaneously, ergothioneine further enhances the antioxidant efficacy of the whitening composition. In summary, the above whitening composition is color-stable and resistant to discoloration, while also providing excellent skin whitening and antioxidant effects. Attached Figure Description
[0023] The above and other features, advantages, and aspects of the embodiments of this disclosure will become more apparent from the accompanying drawings and the following detailed description. Throughout the drawings, the same or similar reference numerals denote the same or similar elements. It should be understood that the drawings are schematic and the elements are not necessarily drawn to scale.
[0024] Figure 1This is a comparison chart of the color stability of Comparative Examples 1, 2, 3, 4, 5, 6, 7, 8, and 9 at 50℃.
[0025] Figure 2 This is a schematic diagram of the appearance of the test sample corresponding to Comparative Example 1;
[0026] Figure 3 This is a schematic diagram of the appearance of the test sample corresponding to Comparative Example 2;
[0027] Figure 4 This is a schematic diagram of the appearance of the test sample corresponding to Comparative Example 9;
[0028] Figure 5 This is a comparison chart of the color stability of Examples 1, 2, 3, 4, 5, 6, 7, 8, and 9 at 50°C.
[0029] Figure 6 This is a schematic diagram of the appearance of the test sample corresponding to Example 1;
[0030] Figure 7 This is a schematic diagram of the appearance of the test sample corresponding to Example 3;
[0031] Figure 8 This is a comparison chart of the color stability of Examples 10, 11, 12, 13, 14, and 15 at 50°C.
[0032] Figure 9 The images show skin images under different spectra based on the whitening test results of Example 1. Detailed Implementation
[0033] Embodiments of this disclosure will now be described in more detail with reference to the accompanying drawings. While some embodiments of this disclosure are shown in the drawings, it should be understood that this disclosure can be implemented in various forms and should not be construed as limited to the embodiments set forth herein. Rather, these embodiments are provided to provide a more thorough and complete understanding of this disclosure. It should be understood that the accompanying drawings and embodiments of this disclosure are for illustrative purposes only and are not intended to limit the scope of protection of this disclosure.
[0034] It should also be noted that, for ease of description, only the parts relevant to the invention are shown in the accompanying drawings. Unless otherwise specified, the embodiments and features described in this disclosure can be combined with each other.
[0035] It should be noted that the terms "a" and "a plurality of" used in this disclosure are illustrative rather than restrictive, and those skilled in the art should understand that, unless otherwise expressly indicated in the context, they should be understood as "one or more".
[0036] It should be noted that when the word “about” is used to limit numerical values, it means ±5% of the specified value.
[0037] It should be noted that the term "%" used in this disclosure, unless otherwise specified, refers to mass.
[0038] It should be noted that "room temperature" as mentioned in this disclosure refers to the ambient temperature, i.e., without any special heating or cooling treatment.
[0039] Terminology Explanation
[0040] The term "tranexamic acid," also known as aminomethylcyclohexane, trans-4-(aminomethyl)cyclohexane, or p-aminomethylcyclohexane, is a synthetic amino acid.
[0041] The term "ascorbate glucoside" refers to a natural form of vitamin C, appearing as a white powder or crystals, readily soluble in water, and containing glucose-stabilizing components. Compared to other vitamin C derivatives, ascorbate glucoside exhibits good stability and solubility in solution. Furthermore, ascorbate glucoside can be used to lighten skin tone and reduce pigmentation in age spots and freckles.
[0042] The term "ergothioneine" refers to a rare, naturally occurring chiral amino acid-based strong oxidant that is highly soluble in water. It possesses cellular physiological protective functions, including scavenging free radicals, detoxification, maintaining DNA biosynthesis, normal cell generation, cellular immunity, skin whitening, and anti-aging.
[0043] The term "phenylethyl resorcinol" is an organic compound with the chemical formula C6H2O. 14 H 14 O2, which appears as a white to light brown powder, is widely used in whitening, spot-removing, and anti-aging products.
[0044] The term "nicotinamide," also known as nicotinamide, is an amide compound of nicotinic acid. It appears as a white crystalline powder and has effects such as preventing rough skin, maintaining healthy skin cells, and promoting skin whitening.
[0045] The term "acetylglucosamine," also known as N-acylglucosamine, has effects such as moisturizing, reducing pigmentation, preventing photoaging, and promoting the normal exfoliation of aged keratinocytes.
[0046] The term "tetrahydrocurcumin" refers to a natural functional whitening ingredient obtained by hydrogenating curcumin isolated from the rhizome of the ginger plant (Curcuma longa). It has significant antioxidant effects and can effectively inhibit the generation of oxygen free radicals and eliminate existing free radicals.
[0047] The term "ellagic acid" is an organic compound with the chemical formula C64-320. 14H6O8 is a natural phenolic antioxidant found in many fruits and vegetables.
[0048] The term "glabridin" refers to a flavonoid extracted from licorice root.
[0049] The term "punicalin" refers to the main component of pomegranate peel polyphenols, which has various effects such as anti-oxidation, anti-cancer, antibacterial, antiviral, and anti-inflammatory properties.
[0050] The term "root bark extract," also known as 2,4,6-trihydroxy-3-(4-hydroxyphenyl)phenylacetone, is a pearly white crystalline powder and a natural skin whitening agent found in the peel and root bark of juicy fruits such as apples and pears.
[0051] The term "methyl chalcone hesperidin," also known as hesperidin methyl chalcone, has the chemical formula C. 29 H 36 O 15 It has the effects of vitamin C and can be used in whitening and spot-removing products, as well as products for preventing and repairing redness.
[0052] The term "glucosyl hesperidin," also known as enzyme-treated hesperidin, is a water-soluble hesperidin derivative that is widely used in food, health products, and cosmetics.
[0053] The term "hesperidin" refers to a flavonoid substance with a dihydroflavonoid oxyglycoside structure. It is weakly acidic and possesses biological activities such as anti-inflammatory, antioxidant, and antibacterial properties.
[0054] The term "naringin" refers to the main flavonoids found in grapefruit. It possesses anti-inflammatory, antiviral, anti-allergic, and analgesic effects.
[0055] The term "resveratrol" refers to a non-flavonoid polyphenolic organic compound with the chemical formula C. 14 H 12 O3.
[0056] The term "ascorbic acid tetraisostearate" refers to a colorless to pale yellow substance with a slight characteristic odor. It is highly stable, not easily oxidized, functions similarly to vitamin C, and is easily absorbed by the skin. Its absorption rate is 16.5 times that of water-soluble vitamin C.
[0057] The term "kojic acid" is an organic compound with the chemical formula C6H6O4, which is commonly used in whitening agents, food additives, preservatives, freshness-preserving agents, and color-protecting agents.
[0058] The term "glutathione" is composed of glutamic acid, cysteine and other amino acids. It has antioxidant properties and is widely used in delaying aging, enhancing immunity and fighting tumors.
[0059] The term "raspberry glucoside" is an active ingredient extracted from raspberry fruit or rhubarb rhizome, and is commonly used as a skin whitening ingredient.
[0060] The term "succinic acid," also known as succinic acid, is a colorless crystal with a sour taste. It has some exfoliating effects, can reduce skin pigmentation, slow down aging, and improve skin tone.
[0061] The term "salicylic acid" refers to an organic acid with the chemical formula C7H6O3. It is a white crystalline powder commonly used to relieve pain and fever, and also has anti-inflammatory properties. Additionally, it can be used for exfoliation.
[0062] The term "acetyltyrosine," also known as N-acetyl-L-tyrosine, appears as white crystals or a crystalline powder, with the chemical formula C1. 11 H 13 NO4.
[0063] The term "diglucosyl gallic acid" has the molecular formula C2. 19 H 26 O 15 It has antioxidant, photoprotective, and melanin-inhibiting effects.
[0064] The term "acetylglucosamine," also known as N-acylglucosamine, has the characteristics of moisturizing, reducing pigmentation, resisting photoaging, and promoting the normal exfoliation of aging keratinocytes.
[0065] The term "heparin sodium" refers to heparin in sodium salt form, which is currently mainly obtained from the small intestinal mucosa of pigs. It has the effects of increasing the vascular permeability of the skin, improving microcirculation, anti-inflammation, anti-allergy, promoting the supply of skin nutrients, promoting the excretion of metabolites, and skin health care and maintenance.
[0066] The term "AHA class," also known as alpha-hydroxy acids, specifically includes glycolic acid, lactic acid, malic acid, etc., which can promote the renewal of epidermal cells, help improve skin tone, and reduce wrinkles.
[0067] The term "BHA class," also known as β-hydroxy acids, specifically includes substances such as salicylic acid, and is often used to treat skin problems such as clogged pores and uneven skin texture.
[0068] The term "azelamide MEA" is a derivative of azelaic acid with the molecular formula Ca. 11 H 21 NO4 has good water solubility.
[0069] The term "potassium 4-methoxysalicylate" has a structure similar to salicylic acid and can coordinate keratin metabolism, correct abnormal epidermal proliferation, and promote melanin removal.
[0070] The term "Polygonum cuspidatum glycoside" refers to an extract from the plant Polygonum cuspidatum, which possesses antioxidant, antitumor, anti-inflammatory, neuroprotective, cardioprotective, and immunomodulatory properties.
[0071] The term "sulforaphane" refers to an isothiocyanate obtained by hydrolysis of glucosinolates by myrosinase in a stagnant body; its chemical formula is C6H2O. 11 NOS2 is a common antioxidant.
[0072] The term "ferulic acid," also known as 4-hydroxy-3-methoxycinnamic acid or 3-(4-hydroxy-3-methoxyphenyl)-2-acrylic acid, or hydroxyphenylacrylic acid, is a phenolic phytochemical found in plant cell walls. It has the effects of preventing lipid oxidation, inhibiting platelet aggregation and thrombosis, improving cardiovascular health, and preventing osteoporosis.
[0073] The term "hydrolyzed conchiolin" refers to peptide compounds obtained by isolating and enzymatically hydrolyzing conchiolin from aquatic organisms using bioengineering techniques. These compounds exhibit strong resistance to melanin production caused by endothelin.
[0074] The term "EGCG", also known as epigallocatechin gallate, is one of the most effective active ingredients in tea polyphenols. It belongs to the catechin family and has antibacterial, antiviral, antioxidant, anti-atherosclerotic, antithrombotic, anti-angiogenic, anti-inflammatory, and anti-tumor effects.
[0075] The term "tartaric acid," also known as 2,3-dihydroxybutyric acid, has the chemical formula C4H6O6.
[0076] The term "nonapeptide-1," also known as a whitening peptide, refers to a nonapeptide containing nine amino acids, often used for skin brightening and blemish removal.
[0077] The term "aloebinin" is an active ingredient in aloe vera, appearing as a pale yellow to brown powder, and possesses anti-inflammatory, UV-protective, and antibacterial properties.
[0078] The term "dihydromyricetin" is mainly composed of flavonoids, which have the effects of scavenging free radicals, anti-oxidation, anti-thrombosis, anti-tumor, and anti-inflammatory.
[0079] The term "papain," also known as papain or papain enzyme, is a cysteine protease found in papaya fruit.
[0080] The term "bromelain," also known as bromelain or pineapple enzyme, is a protease extract derived from pineapple stems.
[0081] The term "sutilanase" refers to a protease isolated from Bacillus subtilis, which has positive effects on skin keratin metabolism and increasing skin elasticity.
[0082] The term "idebenone" is an organic compound with the chemical formula C. 19 H 30 O5 is a yellow crystalline or crystalline powder with effects such as scavenging free radicals, inhibiting lipid peroxidation, inhibiting inflammation, inhibiting DNA damage, photoprotection, and reducing pigmentation.
[0083] The term "astaxanthin" refers to a chain-breaking antioxidant with extremely strong antioxidant capacity and the ability to inhibit lipid peroxidation caused by free radicals.
[0084] The term "hydroxyethylpiperazine ethane sulfonic acid" refers to a highly effective biological buffer that can restructure the stratum corneum and promote the metabolism of skin keratinocytes.
[0085] The term "citric acid," also known as citric acid, is a weak organic acid containing three hydroxyl groups, with the chemical formula C6H8O7.
[0086] The term "sodium citrate," also known as trisodium citrate, has the chemical formula C6H5Na3O7.
[0087] The term "disodium hydrogen phosphate," also known as sodium monohydrogen phosphate, has the chemical formula Na₂HPO₄.
[0088] The term "sodium dihydrogen phosphate," also known as acidic sodium phosphate, has the chemical formula Na₂HPO₄.
[0089] The term "hydroxyethyl cellulose" refers to a white or pale yellow, odorless, non-toxic fibrous or powdery solid with the chemical formula (C2H6O2). n .
[0090] The term "hydroxypropyl cellulose" refers to a semi-synthetic organic compound that is a white or off-white powder.
[0091] The term "hydroxypropyl methylcellulose" refers to a semi-synthetic, inactive, viscoelastic polymer.
[0092] The term "carbomer," also known as polyacrylic acid-hydroxyethylene copolymer, is an important rheology modifier.
[0093] The term "sodium polyacrylate" refers to a novel functional polymer material. In its solid state, it appears as a white or light yellow block or powder, while in its liquid state, it is a colorless or pale yellow viscous liquid. Its chemical formula is (C3H3NaO2). n .
[0094] The term "HEPES", also known as 4-hydroxyethylpiperazine ethanesulfonic acid, is used in commonly used zwitterionic buffer solutions.
[0095] The term "aminomethylpropanol," also known as 2-amino-2-methyl-1-propanol, has the chemical formula C4H. 11 NO appears as white crystalline lumps or a colorless liquid and is commonly used as a biological stabilizer and pH stabilizer.
[0096] This disclosure will now be described in detail with reference to the accompanying drawings and embodiments.
[0097] Experimental Method Description
[0098] Heat resistance stability test
[0099] (1) Seal the experimental samples in 50mL PET bottles and store them in an environment at (50±0.5)℃ away from light. Observe the color stability of the experimental samples every day.
[0100] (2) For the color evaluation of the test samples, the color change of Comparative Example 9 was set as 0 points and the color of deionized water (T100) was set as 10 points. The colors of different compositions were scored.
[0101] Comparison of proportions
[0102] The comparative examples include Comparative Example 1, Comparative Example 2, Comparative Example 3, Comparative Example 4, Comparative Example 5, Comparative Example 6, Comparative Example 7, Comparative Example 8, and Comparative Example 9. The composition ratios of the experimental samples for each comparative example are detailed in Table 1 below:
[0103] Table 1
[0104]
[0105]
[0106] Among them, the color stability of Comparative Examples 1, 2, 3, 4, 5, 6, 7, 8, and 9 at 50℃ is as follows: Figure 1 As shown, the color stability scores for Comparative Examples 1-9 are 7, 4, 7, 2, 1, 1, 4, 5, and 0, respectively. For specific details, the appearance images of the test samples for Comparative Examples 1, 2, and 9 can be found in the respective references. Figure 2 The diagram shown below illustrates the appearance of the test sample corresponding to Comparative Example 1. Figure 3 The diagram showing the appearance of the test sample corresponding to Comparative Example 2, and Figure 4The diagram shown is a schematic representation of the appearance of the test sample corresponding to Comparative Example 9. The comparison reveals that, firstly, Comparative Examples 1 and 8 demonstrate that adding only ascorbate glucoside or ergothioneine cannot completely inhibit discoloration. Secondly, Comparative Examples 2, 4, 5, 6, and 7 demonstrate that combining ascorbate glucoside with other antioxidants (vitamin C ethyl ether, ascorbic acid, ascorbate glucoside salt, and glycyrrhizin) cannot completely inhibit discoloration.
[0107] Example Description
[0108] The examples include Example 1, Example 2, Example 3, Example 4, Example 5, Example 6, Example 7, Example 8, and Example 9. The composition ratios of the experimental samples for each example are detailed in Table 2 below:
[0109] Table 2
[0110]
[0111] In Example 1, the mass ratio of arbutin, tranexamic acid, and color stabilizer was 1:2.5:0.0525; the mass ratio of ascorbate glucoside to ergothioneine was 20:1.
[0112] In Example 2, the mass ratio of arbutin, tranexamic acid, and color stabilizer was 1:2.5:0.505; the mass ratio of ascorbate glucoside to ergothioneine was 100:1.
[0113] In Example 3, the mass ratio of arbutin, tranexamic acid, and color stabilizer was 1:2.5:0.2525; the mass ratio of ascorbate glucoside to ergothioneine was 10:1.
[0114] In Example 4, the mass ratio of arbutin, tranexamic acid, and color stabilizer was 1:5:0.105; the mass ratio of ascorbate glucoside to ergothioneine was 20:1.
[0115] In Example 5, the mass ratio of arbutin, tranexamic acid, and color stabilizer was 1:5:0.505; the mass ratio of ascorbate glucoside to ergothioneine was 100:1.
[0116] In Example 6, the mass ratio of arbutin, tranexamic acid, and color stabilizer was 1:5:0.505; the mass ratio of ascorbate glucoside to ergothioneine was 10:1.
[0117] In Example 7, the mass ratio of arbutin, tranexamic acid, and color stabilizer was 1:0.5:0.0525; the mass ratio of ascorbate glucoside to ergothioneine was 20:1.
[0118] In Example 8, the mass ratio of arbutin, tranexamic acid, and color stabilizer was 1:0.5:0.505; the mass ratio of ascorbate glucoside to ergothioneine was 100:1.
[0119] In Example 9, the mass ratio of arbutin, tranexamic acid, and color stabilizer was 1:0.5:0.2525; the mass ratio of ascorbate glucoside to ergothioneine was 10:1.
[0120] Among them, the color stability of Examples 1, 2, 3, 4, 5, 6, 7, 8, and 9 at 50°C is as follows: Figure 5 As shown, the color stability scores for Examples 1-9 are 9, 9.5, 10, 9.1, 9.8, 10, 8.9, 9.5, and 9.5, respectively. For details, the appearance diagrams of the test samples for Examples 1 and 3 can be found in the following references. Figure 6 The diagram shown is a schematic representation of the appearance of the test sample corresponding to Example 1. Figure 7 The diagram shows the appearance of the test sample corresponding to Example 3. Comparison revealed that Examples 1 to 9 demonstrated that the composition remained completely colorless; that is, when the mass ratio of tranexamic acid, arbutin, and color stabilizer was 1:0.5–5:0.05–1.0, and the mass ratio of ascorbate glucoside and ergothioneine was 100:1–10:1, the color change of the tranexamic acid combination could be completely suppressed.
[0121] Furthermore, Examples 10, 11, 12, 13, 14, and 15 were further established. The composition ratios of the experimental samples corresponding to each example are detailed in Table 3 below:
[0122] Table 3
[0123]
[0124] In Example 10, the mass ratio of arbutin, tranexamic acid, and color stabilizer was 1:2.5:0.5025; the mass ratio of ascorbate glucoside to ergothioneine was 200:1.
[0125] In Example 11, the mass ratio of arbutin, tranexamic acid, and color stabilizer was 1:2.5:0.0625; the mass ratio of ascorbate glucoside to ergothioneine was 4:1.
[0126] In Example 12, the mass ratio of arbutin, tranexamic acid, and color stabilizer was 1:5:1.005; the mass ratio of ascorbate glucoside to ergothioneine was 200:1.
[0127] In Example 13, the mass ratio of arbutin, tranexamic acid, and color stabilizer was 1:5:0.125; the mass ratio of ascorbate glucoside to ergothioneine was 4:1.
[0128] In Example 14, the mass ratio of arbutin, tranexamic acid, and color stabilizer was 1:0.5:0.5025; the mass ratio of ascorbate glucoside to ergothioneine was 200:1.
[0129] In Example 15, the mass ratio of arbutin, tranexamic acid, and color stabilizer was 1:0.5:0.0625; the mass ratio of ascorbate glucoside to ergothioneine was 4:1.
[0130] Among them, the color stability of Examples 10, 11, 12, 13, 14, and 15 at 50°C is as follows: Figure 8 As shown, the color stability scores corresponding to Examples 10-15 are 10, 9.5, 9.8, 9.2, 10, and 9.5, respectively. The comparison shows that Examples 10 to 14 prove that the composition does not change color at all.
[0131] Application Examples
[0132] Application Example 1
[0133] The skin whitening product prepared using Example 1 is a whitening essence. The formula for the whitening essence is detailed in Table 4 below:
[0134] Table 4
[0135]
[0136] Preparation method of whitening essence:
[0137] S1: Heat phase A to 65-75 degrees Celsius until it dissolves and becomes homogeneous.
[0138] S2: Add phase B to the system, stir well, and start cooling.
[0139] S3: Cool to 45±1℃ and add phase C to the system sequentially, stirring until dissolved and homogeneous.
[0140] S4: Cool to room temperature, pass inspection, and discharge to obtain the above-mentioned whitening essence.
[0141] Whitening efficacy test
[0142] Among them, the skin whitening effect of the samples was tested using the ultraviolet-induced human skin melanization model whitening efficacy test method.
[0143] Subject selection
[0144] Among them, qualified subjects were selected according to the inclusion and exclusion criteria to ensure that the final number of valid cases in each test area was no less than 30.
[0145] Test substance preparation
[0146] Among them, the test product is the test sample. The negative control is a blank control in the blackened area. The positive control is a 7% ascorbic acid topical skin product.
[0147] Specific testing steps
[0148] Determine the MED (Medium Effective Drug) at the test site for each subject. Then, select test areas at the test site and irradiate them once a day at the same irradiation point using a sunlight simulator at a dose of 0.75 times the MED, for 4 consecutive days. On the 5th day after the irradiation ends, visually evaluate the skin color of each test area and perform skin color instrument testing. Test areas with poor consistency (areas where the ITA° value differs from the mean of all test areas by more than 5) should be removed.
[0149] On the same day, the corresponding test samples were applied to each blackening test area according to a random table. Staff applied the test samples to the corresponding test areas according to the random table, ensuring the applied area was no less than 6 cm². 2 The sample application rate was 2.00 ± 0.05 mg / cm³. 2 Apply the test substance continuously for at least 4 weeks. Visual assessment and instrumental testing of skin color should be performed at 1, 2, 3, and 4 weeks after application, and the results should be recorded. At each visit, the L*, a*, and b* values of each test area should be measured using a skin colorimeter. Each area should be tested three times, and the ITA° value should be recorded and calculated. The higher the ITA° value, the lighter the skin tone, and vice versa. The ITA° value A before using the sample and the ITA° value B after using the sample are used to calculate the improvement percentage. (AB) / A*100% represents the product's improvement percentage.
[0150] After whitening efficacy testing, this product showed an average ITA increase of 12% during a 28-day trial. See also... Figure 8 The skin imaging results of the whitening test in Application Example 1 shown in different spectra show that the skin color becomes significantly lighter over time after using the test sample, which further confirms that the composition has a significant whitening effect.
[0151] The above description is merely a selection of preferred embodiments of this disclosure and an explanation of the technical principles employed. Those skilled in the art should understand that the scope of the invention involved in the embodiments of this disclosure is not limited to technical solutions formed by specific combinations of the above-described technical features, but should also cover other technical solutions formed by arbitrary combinations of the above-described technical features or their equivalents without departing from the above-described inventive concept. For example, technical solutions formed by substituting the above-described features with (but not limited to) technical features with similar functions disclosed in the embodiments of this disclosure.
Claims
1. Use of a combination of ascorbyl glucoside and ergothioneine as a color stabilizer in the manufacture of a whitening composition, wherein, The skin-whitening composition includes arbutin and tranexamic acid.
2. The use according to claim 1, wherein, The mass ratio of arbutin to tranexamic acid is 1:0.5~5.
3. The application according to claim 2, wherein, The mass ratio of arbutin to the color stabilizer is 1:0.05~1.
4. The application according to claim 1, wherein, The mass ratio of ascorbate glucoside to ergothioneine is 10~100:
1.
5. The application according to claim 1, wherein, The whitening composition also includes one or more of a pH adjuster or a skin feel adjuster.
6. The application according to claim 5, wherein, The skin feel modifier includes one or more of the following: humectants, emulsifiers, thickeners, or surfactants.
Citation Information
Patent Citations
Skin-whitening and skin-tendering cosmetic raw material composition and application thereof
CN109528548A
Composition for whitening skin, raw materials and external skin preparation
CN116509743A
Self tanning compositions containing dihydroxyacetone, a retinoid and ascorbic acid glucoside as a stabilizer
KR1020100041684A
